Abstract
e12023Background: The neutrophil-to-lymphocyte ratio (NLR) is a strong predictor of mortality in patients with pancreatic, colorectal, lung, gastric cancer and renal cell carcinoma. The aim of this study was to determine the relationship between pathological complete response (pCR) and pretreatment NLR values with overall survival in locally advanced breast cancer (LABC) patients receiving neoadjuvant chemotherapy (NACT) at the National Cancer Institute (NCI) of Mexico. Methods: Data were retrospectively collected from the Database of the NCI for LABC patients treated with NACT (including trastuzumab for HER2+ tumors) between January 2007- December 2010. We evaluated data of 690 patients (pts). Patients without complete pathology reports, laboratory test results, inflammatory (T4d) or pregnancy related BC were excluded. Pts who were diagnosed with chronic liver disease, end stage renal disease or any inflammatory disease such as SLE were also excluded. The pretreatment blood count data was retrieved from ...
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
